4-NITROBENZYL (R)-4-((2R,3S)-3-((R)-1-((TERT-BUTYLDIMETHYLSILYL)OXY)ETHYL)-4-OXOAZETIDIN-2-YL)-2-DIAZO-3-OXOPENTANOATE
UNII F6J894HB5M

Substance Identification & Data

This profile provides standardized clinical and technical data for 4-nitrobenzyl (r)-4-((2r,3s)-3-((r)-1-((tert-butyldimethylsilyl)oxy)ethyl)-4-oxoazetidin-2-yl)-2-diazo-3-oxopentanoate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) F6J894HB5M.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 110312-12-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

F6J894HB5M

CAS Registry Number

110312-12-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

4-NITROBENZYL (R)-4-((2R,3S)-3-((R)-1-((TERT-BUTYLDIMETHYLSILYL)OXY)ETHYL)-4-OXOAZETIDIN-2-YL)-2-DIAZO-3-OXOPENTANOATE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C23H32N4O7Si

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

AITJUODELMLHPL-DTTOXWODSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

135518349

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[C@@H](O[Si](C(C)(C)C)(C)C)(C)[C@@]1([C@@]([C@H](C(C(C(OCc2ccc([N+]([O-])=O)cc2)=O)=[N+]=[N-])=O)C)(NC1=O)[H])[H]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 4-nitrobenzyl (r)-4-((2r,3s)-3-((r)-1-((tert-butyldimethylsilyl)oxy)ethyl)-4-oxoazetidin-2-yl)-2-diazo-3-oxopentanoate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Systematic Nomenclature

(4-NITROPHENYL)METHYL (.GAMMA.R,2R,3S)-.ALPHA.-DIAZO-3-((1R)-1-(((1,1-DIMETHYLETHYL)DIMETHYLSILYL)OXY)ETHYL)-.GAMMA.-METHYL-.BETA.,4-DIOXO-2-AZETIDINEBUTANOATE

SYS

2-AZETIDINEBUTANOIC ACID, .ALPHA.-DIAZO-3-((1R)-1-(((1,1-DIMETHYLETHYL)DIMETHYLSILYL)OXY)ETHYL)-.GAMMA.-METHYL-.BETA.,4-DIOXO-, (4-NITROPHENYL)METHYL ESTER, (.GAMMA.R,2R,3S)-

SYS

2-AZETIDINEBUTANOIC ACID, .ALPHA.-DIAZO-3-(1-(((1,1-DIMETHYLETHYL)DIMETHYLSILYL)OXY)ETHYL)-.GAMMA.-METHYL-.BETA.,4-DIOXO-, (4-NITROPHENYL)METHYL ESTER, (2R-(2.ALPHA.(R*),3.BETA.(R*)))-

SYS

4-NITROBENZYL (R)-4-((2R,3S)-3-((R)-1-((TERT-BUTYLDIMETHYLSILYL)OXY)ETHYL)-4-OXOAZETIDIN-2-YL)-2-DIAZO-3-OXOPENTANOATE

SYS

External Clinical & Regulatory Resources

Previous UNIIF6J6Y9R4HT

Next UNIIF6JD35PUZ7